Abbott Drops Patent Claims Over Teva's Generic Simcor

Law360, New York (January 4, 2012, 4:48 PM EST) -- Abbott Laboratories on Tuesday dropped five consolidated patent infringement suits against Teva Pharmaceuticals Industries Ltd. over Teva's attempts to market a generic version of Abbott's cholesterol drug Simcor.

According to a joint stipulation of dismissal filed in a Delaware federal court last week, the parties agreed to pay their own costs and neither admitted to liability in the two-year-old dispute. U.S. District Judge Sue Robinson signed an order dismissing the cases with prejudice Tuesday.

Abbott and Abbott Respiratory LLC lodged the most recent complaint in August...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Abbott Laboratories et al v. Watson Laboratories Inc. - Florida


Case Number

1:10-cv-00057

Court

Delaware

Nature of Suit

Patent

Judge

Sue L. Robinson

Date Filed

January 22, 2010


Case Title

Abbott Laboratories et al v. Teva Pharmaceutical Industries Ltd. et al


Case Number

1:11-cv-00239

Court

Delaware

Nature of Suit

Patent

Judge

Sue L. Robinson

Date Filed

March 21, 2011


Case Title

Abbott Laboratories et al v. Teva Pharmaceutical Industries Ltd et al


Case Number

1:10-cv-00302

Court

Delaware

Nature of Suit

Patent

Judge

Sue L. Robinson

Date Filed

April 14, 2010


Case Title

Abbott Laboratories et al v. Teva Pharmaceuticals USA Inc. et al


Case Number

1:11-cv-00712

Court

Delaware

Nature of Suit

Patent

Judge

Sue L. Robinson

Date Filed

August 12, 2011


Case Title

Abbott Laboratories et al v. Teva Pharmaceutical Industries Ltd. et al


Case Number

1:10-cv-00766

Court

Delaware

Nature of Suit

Patent

Judge

Sue L. Robinson

Date Filed

September 8, 2010

Law Firms

Companies

Government Agencies

Patents